Yasutsugu Ueda
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Synthesis of β-Lactam Compounds, Antibiotics Pharmacokinetics and Efficacy, Microbial Natural Products and Biosynthesis, Antibiotic Resistance in Bacteria
Most-Cited Works
- → In VitroAntiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068(2012)138 cited
- → Envelope Conformational Changes Induced by Human Immunodeficiency Virus Type 1 Attachment Inhibitors Prevent CD4 Binding and Downstream Entry Events(2006)108 cited
- → Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics(2004)100 cited
- → Michael Addition of Amines and Thiols to Dehydroalanine Amides: A Remarkable Rate Acceleration in Water(2003)71 cited
- → Novel water soluble phosphate prodrugs of taxol® possessing in vivo antitumor activity(1993)71 cited
- → Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: Synthesis and biological properties(2003)57 cited
- → Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)(2012)49 cited
- → Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics(2004)49 cited
- → Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors(2014)47 cited
- → Synthesis, in vitro, and in vivo antibacterial activity of nocathiacin I thiol-Michael adducts(2005)47 cited